Exploration of organoid in breast cancer related research.
- Author:
Xiao ZHENG
1
;
Jiajun LI
1
;
Jie SHENG
1
;
Qing ZHUO
1
;
Qing DU
1
;
Yao XU
1
Author Information
- Publication Type:Review
- Keywords: 3D culture; breast cancer cell line; organoid; personalized medication
- MeSH: Animals; Breast Neoplasms; Cell Culture Techniques; Female; Humans; Organoids; Precision Medicine; Research
- From: Chinese Journal of Biotechnology 2021;37(2):395-403
- CountryChina
- Language:Chinese
- Abstract: Breast cancer is the most common cancer in women. At present, the in vivo model and traditional cell culture are mainly used in breast cancer researches. However, as high as 90% clinical trials are failed for drugs explored by the above two methods, due to the inherent species differences between humans and animals, as well as the differences in the tissue structure between organs and cells. Therefore, organoid three-dimensional culture is emerging. As a new tumor research model, organoid, a three-dimensional cell complex with spatial structure, has broad application prospects, such as precision medicine, organ transplantation, establishment of refractory disease model, gene therapy and drug research and development. Therefore, organoid is considered as one of the ideal carriers for life science research in the future. Breast cancer, a heterogeneous disease with complex phenotypes, has a low survival rate. Breast cancer organoid can reproduce many key features of human breast cancer, thus, the construction of organoid biological library of breast cancer will provide a new platform for studying the occurrence, development, metastasis and drug resistance mechanism of breast cancer. In this review, we systematically introduce the culture conditions of organoids and their application in breast cancer related research, and the application prospect of organoids.
